Auddia Announces Influence Healthcare’s First Specialty Hospital LOI, Marking a Major Milestone in the Company’s Healthcare Expansion
Rhea-AI Summary
Auddia (NASDAQ: AUUD)/b) announced that portfolio company signed a Letter of Intent to sublease, and later assume the master lease of, a 24,000-square-foot specialty hospital in the Dallas–Fort Worth MSA, featuring four operating rooms focused on spine and orthopedic surgery.
According to Auddia, each OR is expected to support $5M–$10M in annual revenue, aligning with Influence Healthcare’s AI-enabled, value-based care model. The LOI targets hospital delivery and operational occupancy by June 1, 2027, and outlines a transition from sublease to full master lease assignment running through January 24, 2036, contingent on operational, financial, and regulatory performance criteria. This is positioned as Influence Healthcare’s first operational hospital and an early milestone for the businesses expected to form McCarthy Finney under Auddia’s proposed merger with Thramann Holdings.
Positive
- First specialty hospital secured via LOI for Influence Healthcare, a 24,000-square-foot facility with four ORs in Dallas–Fort Worth
- Each OR expected to generate $5M–$10M annually, supporting Influence Healthcare’s high-margin, value-based care business model
- Long-term lease runway through January 24, 2036 via structured transition from sublease to full master lease assignment
- Defines clear performance criteria including case volumes, surgeon panel, payer contracts, licensing, and liquidity for lease assignment
- First real-world deployment of Influence Healthcare’s AI-enabled, surgeon-led value-based care model in a hospital setting
- Supports strategic rationale for Auddia’s proposed merger creating McCarthy Finney with Influence Healthcare as a key portfolio company
Negative
- Lease not yet finalized, with the company expecting to sign the definitive lease agreement within the next 60 days
- Operational start targeted no later than June 1, 2027, implying a multi-year gap before the hospital potentially contributes revenue
- Lease assignment dependent on multiple conditions such as minimum surgical volumes, surgeon panels, payer contracts, licensing, and liquidity thresholds
Market reaction after specialty hospital LOI: AUUD +20.53%
Following this news, AUUD has gained 20.53%, reflecting a significant positive market reaction. Argus tracked a trough of -6.8% from its starting point during tracking. Our momentum scanner has triggered 32 alerts so far, indicating elevated trading interest and price volatility. The stock is currently trading at $1.19. Trading volume is exceptionally heavy at 280.3x the average, suggesting very strong buying interest.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 26 | CEO media appearance | Positive | +3.1% | CEO scheduled to discuss LT350’s distributed data-center strategy on Fox Business |
| Aug 25 | AI development model | Positive | -4.7% | Company reported faster feature delivery and reduced engineering resource requirements |
| Aug 17 | Label partnership | Positive | -3.7% | AMG Corp selected Discovr Radio as its exclusive digital radio release channel |
| Aug 12 | Merger proxy filing | Positive | -12.0% | Definitive proxy filed and shareholder meeting scheduled for merger vote |
| Aug 10 | Merger regulatory milestone | Positive | +60.5% | SEC declared the Form S-4 registration statement effective for proposed merger |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AUUD aligned with positive reactions twice, but diverged on three other recent positive or transaction-related announcements.
Key Terms
loi financial
sublease financial
master lease financial
value-based care medical
form s-4 regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Secures 24,000-square-foot Texas specialty hospital with four operating rooms
LOI establishes Influence Healthcare occupancy of the hospital no later than June 1, 2027
Each OR is expected to drive
BOULDER, Colo., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ: AUUD) (“Auddia” or the “Company”), an AI-first technology company pursuing a merger to form McCarthy Finney, an AI native operating company, today announced that Influence Healthcare has signed a Letter of Intent (LOI) to sublease, and ultimately assume the master lease of, a specialty hospital located in the Dallas Fort Worth MSA. The facility is 24,000 square feet, has four operating rooms, and will serve as Influence Healthcare’s first operational hospital, focused on spine and orthopedic surgery, marking a major milestone in the company’s growth strategy.
Influence Healthcare is one of three businesses expected to join Auddia as part of its proposed business combination with Thramann Holdings, LLC, which would result in the formation of McCarthy Finney. This milestone provides an early example of the operating progress underway within the businesses expected to comprise McCarthy Finney.
“This LOI represents a foundational moment for Influence Healthcare,” said Jeff Thramann, M.D., CEO of Auddia and Founder of Influence Healthcare. “Securing our first specialty hospital accelerates our ability to generate revenue, build our surgical network, and demonstrate the scalability of our value-based care model. With specialty hospital ORs for spine and orthopedics generating
Under the LOI, Influence Healthcare will begin operating the hospital upon delivery of the premises, which is expected no later than June 1, 2027. The agreement provides a structured pathway for Influence Healthcare to transition from an initial sublease into a full assignment of the master lease, which runs through January 24, 2036, upon meeting defined operational, financial, and regulatory performance criteria. These include minimum surgical case volumes, surgeon panel requirements, payer contracting, hospital licensing, and liquidity thresholds.
Influence Healthcare Brings AI-Enabled Operations to Specialty Care
Influence Healthcare’s entry into hospital operations marks the first real-world deployment of its physician-led, AI-enabled, value-based care model. The company is pursuing vertically integrated hospitals where AI streamlines critical clinical, administrative, and operational workflows including clinical documentation, coding and billing, prior authorization, care coordination, and supply chain logistics, while surgeons are empowered to practice with greater autonomy, less administrative drag, and greater control over clinical quality and value.
Securing its first hospital represents a critical transition from concept to execution as Influence Healthcare is now positioned to prove that AI-driven operations and surgeon-led governance can deliver superior outcomes at lower cost.
The hospital will operate as part of a Value Based Enterprise under Influence Healthcare’s physician-aligned VBC model while maintaining compliance with all licensing, accreditation, and regulatory requirements outlined in the LOI. The facility includes full hospital infrastructure, parking access, signage rights, and the ability to assume all permits and licensed beds upon assignment.
For information about Influence Healthcare, please visit www.influencehealthcare.com
About the Merger to form McCarthy Finney
Auddia entered into a definitive merger agreement on February 17, 2026. The merger contemplates a business combination between Auddia Inc. and Thramann Holdings, LLC, a single member Colorado LLC. Thramann Holdings fully owns LT350, Influence Healthcare, and Voyex, three early-stage AI native operating companies. Upon merger completion, Auddia will change its name to McCarthy Finney and trade under the ticker MCFN. McCarthy Finney is an AI holding company that will deliver AI and Web3 services to its four portfolio companies: LT350, Influence Healthcare, Voyex, and Auddia.
- LT350 is a distributed AI data center company with 13 issued, 1 allowed, and 2 pending patents on a proprietary solar parking lot canopy infrastructure platform that integrates modular battery storage and GPU cartridges into the ceiling of the canopy to turn any parking lot into an AI data center. The Company aims to build the most secure, lowest latency, cost- effective, and rapidly deployed network of distributed AI data centers at the edge by leveraging the use of underutilized parking lot space while strengthening the existing power infrastructure of local utilities.
- Influence Healthcare is a health-tech company leveraging AI, blockchain, and vertical integration to empower surgeons to drive adoption of value-based care (VBC) to the surgical specialties. The Company’s mission is to leverage technology and value based enterprises (VBEs) to build an alternative healthcare system that minimizes the corporate practice of medicine, eliminates administrative waste, and enhances the autonomy and pay of health care providers to empower them to improve quality and return the patient physician relationship to the center of medicine.
- Voyex is a travel services platform that leverages agentic AI, an integrated fintech platform, and utilization of charter and private jet aircraft to significantly improve the travel experience. The Company aims to alleviate the leading pain points for travelers of lengthy flight delays and cancellations.
About Auddia Inc.
Auddia, through its proprietary AI platform for audio identification and classification, is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. Auddia’s Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Auddia’s flagship audio superapp, called faidr, delivers multiple industry firsts, including:
- Ad-free listening on any AM/FM radio station
- Content skipping across any AM/FM station
- One-touch skipping of entire podcast ad breaks
- Integrated artist discovery experiences
For more information, visit www.auddia.com.
Cautionary Note on Forward-Looking Statements
Certain statements in this communication, other than purely historical information, may constitute “forward-looking statements” within the meaning of the federal securities laws, including for purposes of the “safe harbor” provisions under the Private Securities Litigation Reform Act of 1995, concerning Auddia, Thramann Holdings, and the proposed merger between Auddia and Thramann Holdings (the “Proposed Transaction”) and other matters. These forward-looking statements include, but are not limited to, express or implied statements relating to Auddia’s and Thramann Holdings’ management expectations, hopes, beliefs, intentions or strategies regarding the future including, without limitation, statements regarding: the structure, timing and completion of the proposed merger by and between Auddia and Thramann Holdings, and the expected effects, perceived benefits or opportunities of the Proposed Transaction; the combined company’s listing on Nasdaq after the closing of the Proposed Transaction; expectations regarding the structure, timing and completion of the financing needed to close the Proposed Transaction, including investment amounts from investors, timing of closing of the Proposed Transaction, expected proceed, expectations regarding the use of proceeds, and impact on ownership structure; the anticipated timing of the closing; the expected executive officers and directors of the combined company; each company’s and the combined company’s expected cash position at the closing and cash runway of the combined company following the proposed merger and any additional financing; the future operations of the combined company, including research and development activities; the nature, strategy and focus of the combined company; the development and commercial potential and potential benefits of any products and services of the combined company; the cash balance of the combined entity at closing; expectations related to the anticipated timing of the closing of the Proposed Transaction (the “Closing”); the expectations regarding the ownership structure of the combined company; the expected trading of the combined company’s stock on Nasdaq under the ticker symbol “MCFN” after the Closing; and other statements that are not historical fact.
All statements other than statements of historical fact contained in this communication are forward-looking statements. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “opportunity,” “potential,” “milestones,” “pipeline,” “can,” “goal,” “strategy,” “target,” “anticipate,” “achieve,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “plan,” “possible,” “project,” “should,” “will,” “would” and similar expressions (including the negatives of these terms or variations of them) may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are made based on current expectations, estimates, forecasts, and projections, as well as the beliefs and assumptions of management, concerning future developments and their potential effects. There can be no assurance that future developments affecting Auddia, Thramann Holdings, or the Proposed Transaction will be those that have been anticipated.
These forward-looking statements involve a number of risks and uncertainties, some of which are beyond Auddia’s or Thramann Holdings’ control, or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that the conditions to the Closing or consummation of the Proposed Transaction are not satisfied, including the failure to timely obtain approval of the proposed merger from Auddia’s stockholders the risk that the required financing is not obtained in a timely manner, if at all; uncertainties as to the timing of the consummation of the Proposed Transaction; risks related to Auddia’s continued listing on Nasdaq until closing of the Proposed Transaction and the combined company’s ability to remain listed following the Closing; uncertainties regarding the impact any delay in the Closing would have on the anticipated cash resources of the combined company, and other events and unanticipated spending and costs that could reduce the combined company’s cash resources; the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the merger agreement; the effect of the announcement or pendency of the merger on Auddia’s or Thramann Holdings’ business relationships, operating results and business generally; costs related to the merger; the risk that as a result of adjustments to the exchange ratio, Auddia’s or Thramann Holdings’ stockholders could own more or less of the combined company than is currently anticipated; risks related to the market price of Auddia’s common stock relative to the value suggested by the exchange ratio; risks related to the inability of the combined company to obtain sufficient additional capital to continue to advance the development of its products and services; costs of the Proposed Transaction and unexpected costs, charges or expenses resulting from the Proposed Transaction; potential adverse reactions or changes to business relationships, operating results, and business generally, resulting from the announcement or completion of the Proposed Transaction;
Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties. These and other risks and uncertainties are more fully described in periodic filings with the SEC, including the factors described in the section titled “Risk Factors” in Auddia’s Annual Report on Form 10-K for the year ended December 31, 2025, which was originally filed with the SEC on March 6, 2026, subsequent Quarterly Reports on Form 10-Q filed with the SEC, and in other filings that Auddia makes and will make with the SEC in connection with the Proposed Transaction, including the Form S-4 and Proxy Statement described below, as well as discussions of potential risks, uncertainties, and other important factors included in other filings by Auddia from time to time. Should one or more of these risks or uncertainties materialize, or should any of Auddia’s or Thramann Holdings’ assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. Neither Auddia nor Thramann Holdings undertakes or accepts any duty to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based, except as required by law. This communication does not purport to summarize all of the conditions, risks and other attributes of an investment in Auddia or Thramann Holdings.
No Offer or Solicitation
This communication and the information contained herein is not intended to and does not constitute (i) a solicitation of a proxy, consent or approval with respect to any securities or in respect of the proposed transaction or (ii) an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities pursuant to the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law, or an exemption therefrom. Subject to certain exceptions to be approved by the relevant regulators or certain facts to be ascertained, the public offer will not be made directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce, or any facility of a national securities exchange, of any such jurisdiction.
NEITHER THE SEC NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE SECURITIES OR DETERMINED IF THIS COMMUNICATION IS TRUTHFUL OR COMPLETE.
Important Additional Information about the Proposed Transaction Will be Filed with the SEC
This communication relates to the proposed merger involving Auddia and Thramann Holdings and may be deemed to be solicitation material in respect of the proposed merger. In connection with the proposed Transaction, Auddia intends to file relevant materials with the SEC, including a registration statement on Form S-4 (the “Form S-4”) that will contain a proxy statement (the “Proxy Statement”) and prospectus. This communication is not a substitute for the Form S-4, the Proxy Statement or for any other document that Auddia may file with the SEC and/or send to Auddia’s stockholders in connection with the proposed merger. AUDDIA URGES, BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS TO READ THE FORM S-4, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT AUDDIA, THRAMANN HOLDINGS, THE PROPOSED TRANSACTION AND RELATED MATTERS.
Investors and stockholders will be able to obtain free copies of the Form S-4, the Proxy Statement and other documents filed by Auddia with the SEC (when they become available) through the website maintained by the SEC at www.sec.gov. Copies of the documents filed by Auddia with the SEC will also be available free of charge on Auddia’s website at www.auddia.com, or by contacting Auddia’s Investor Relations at investors.auddiainc.com/contact. In addition, investors and stockholders should note that Auddia communicates with investors and the public using its website at investors.auddiainc.com.
Participants in the Solicitation
Auddia, Thramann Holdings, and their respective directors and certain of their executive officers and other members of management may be deemed to be participants in the solicitation of proxies from Auddia’s stockholders in connection with the proposed transaction under the rules of the SEC. Information about Auddia’s directors and executive officers, including a description of their interests in Auddia, is included in Auddia’s most recent Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the SEC on March 6, 2026. Additional information regarding the persons who may be deemed participants in the proxy solicitations, including about the directors and executive officers of Thramann Holdings, and a description of their direct and indirect interests, by security holdings or otherwise, will also be included in the Form S-4, the Proxy Statement and other relevant materials to be filed with the SEC when they become available. These documents can be obtained free of charge from the sources indicated above.
Investor Relations:
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com
www.pcgadvisory.com
